rs2287779

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_002454.3(MTRR):​c.1155G>A​(p.Leu385Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0397 in 1,613,972 control chromosomes in the GnomAD database, including 2,193 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.044 ( 274 hom., cov: 32)
Exomes 𝑓: 0.039 ( 1919 hom. )

Consequence

MTRR
NM_002454.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 3.54

Publications

22 publications found
Variant links:
Genes affected
MTRR (HGNC:7473): (5-methyltetrahydrofolate-homocysteine methyltransferase reductase) This gene encodes a member of the ferredoxin-NADP(+) reductase (FNR) family of electron transferases. This protein functions in the synthesis of methionine by regenerating methionine synthase to a functional state. Because methionine synthesis requires methyl-group transfer by a folate donor, activity of the encoded enzyme is important for folate metabolism and cellular methylation. Mutations in this gene can cause homocystinuria-megaloblastic anemia, cbl E type. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Dec 2015]
MTRR Gene-Disease associations (from GenCC):
  • methylcobalamin deficiency type cblE
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.32).
BP6
Variant 5-7889103-G-A is Benign according to our data. Variant chr5-7889103-G-A is described in ClinVar as Benign. ClinVar VariationId is 138292.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=3.54 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.176 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MTRRNM_002454.3 linkc.1155G>A p.Leu385Leu synonymous_variant Exon 9 of 15 ENST00000440940.7 NP_002445.2 Q9UBK8-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MTRRENST00000440940.7 linkc.1155G>A p.Leu385Leu synonymous_variant Exon 9 of 15 1 NM_002454.3 ENSP00000402510.2 Q9UBK8-2

Frequencies

GnomAD3 genomes
AF:
0.0440
AC:
6696
AN:
152062
Hom.:
273
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0243
Gnomad AMI
AF:
0.0581
Gnomad AMR
AF:
0.0875
Gnomad ASJ
AF:
0.0118
Gnomad EAS
AF:
0.185
Gnomad SAS
AF:
0.0383
Gnomad FIN
AF:
0.0713
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.0334
Gnomad OTH
AF:
0.0431
GnomAD2 exomes
AF:
0.0612
AC:
15393
AN:
251406
AF XY:
0.0556
show subpopulations
Gnomad AFR exome
AF:
0.0255
Gnomad AMR exome
AF:
0.140
Gnomad ASJ exome
AF:
0.0136
Gnomad EAS exome
AF:
0.184
Gnomad FIN exome
AF:
0.0697
Gnomad NFE exome
AF:
0.0332
Gnomad OTH exome
AF:
0.0473
GnomAD4 exome
AF:
0.0392
AC:
57359
AN:
1461792
Hom.:
1919
Cov.:
31
AF XY:
0.0386
AC XY:
28063
AN XY:
727204
show subpopulations
African (AFR)
AF:
0.0232
AC:
776
AN:
33480
American (AMR)
AF:
0.135
AC:
6038
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.0135
AC:
354
AN:
26136
East Asian (EAS)
AF:
0.174
AC:
6900
AN:
39698
South Asian (SAS)
AF:
0.0344
AC:
2964
AN:
86250
European-Finnish (FIN)
AF:
0.0678
AC:
3623
AN:
53402
Middle Eastern (MID)
AF:
0.00679
AC:
39
AN:
5742
European-Non Finnish (NFE)
AF:
0.0308
AC:
34240
AN:
1111970
Other (OTH)
AF:
0.0402
AC:
2425
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
2893
5787
8680
11574
14467
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1398
2796
4194
5592
6990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0440
AC:
6698
AN:
152180
Hom.:
274
Cov.:
32
AF XY:
0.0469
AC XY:
3491
AN XY:
74386
show subpopulations
African (AFR)
AF:
0.0244
AC:
1014
AN:
41544
American (AMR)
AF:
0.0874
AC:
1337
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.0118
AC:
41
AN:
3470
East Asian (EAS)
AF:
0.185
AC:
953
AN:
5138
South Asian (SAS)
AF:
0.0381
AC:
184
AN:
4824
European-Finnish (FIN)
AF:
0.0713
AC:
755
AN:
10588
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.0334
AC:
2270
AN:
68006
Other (OTH)
AF:
0.0417
AC:
88
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
321
641
962
1282
1603
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
74
148
222
296
370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0409
Hom.:
184
Bravo
AF:
0.0447
Asia WGS
AF:
0.117
AC:
406
AN:
3478
EpiCase
AF:
0.0266
EpiControl
AF:
0.0279

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Jan 23, 2014
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Disorders of Intracellular Cobalamin Metabolism Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Methylcobalamin deficiency type cblE Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Methylcobalamin deficiency type cblE;C1866558:Neural tube defects, folate-sensitive Benign:1
Oct 27, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.32
CADD
Benign
7.9
DANN
Benign
0.97
PhyloP100
3.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=90/10
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2287779; hg19: chr5-7889216; COSMIC: COSV99241337; COSMIC: COSV99241337; API